LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

LLY

981.8

-1.41%↓

JNJ

199.89

-0.85%↓

ABBV

222.81

-0.04%↓

UNH

323.54

+0.12%↑

AZN

89.56

-1.8%↓

Начало・Списък с акции・Fulgent Genetics Inc

Fulgent Genetics Inc

Отворен

СекторЗдравеопазване

27.41 -1.58

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

27.2

Максимум

27.81

Ключови измерители
By Trading Economics
Приходи	12M -6.8M
Продажби	2.3M 84M
Марж на печалбата	-8.12
Служители	1,313
EBITDA	15M -77K

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+16.65% upside

Пазарни показатели
By TradingEconomics
Пазарна капитализация	174M 882M
Предишно отваряне	28.99
Предишно затваряне	27.41

Настроения в новините

By Acuity

50%

166 / 374 Класиране в Healthcare

Техническа оценка

By Trading Central

Увереност

Bearish Evidence

17.32 / 19.04 Подкрепа & съпротива

Fulgent Genetics Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

8.12.2025 г., 23:48 ч. UTC

Значими двигатели на пазара

Shares of Sezzle and Vital Farms Rise on S&P SmallCap 600 Inclusion

8.12.2025 г., 23:44 ч. UTC

Пазарно говорене

Perky Australian Dollar Looks to Extend Gains -- Market Talk

8.12.2025 г., 23:42 ч. UTC

Пазарно говорене

Nikkei May Decline Amid Uncertainty Over Econ, Earnings -- Market Talk

8.12.2025 г., 23:13 ч. UTC

Пазарно говорене

Global Forex and Fixed Income Roundup: Market Talk

8.12.2025 г., 23:13 ч. UTC

Пазарно говорене

Australian Inflation Expectations Highest Since Late 2023 -- Market Talk

8.12.2025 г., 23:09 ч. UTC

Придобивния, сливания и поглъщания

Paramount Made a Hostile Bid for Warner After Netflix Deal. What Happens Next? -- WSJ

8.12.2025 г., 22:46 ч. UTC

Пазарно говорене

Rio Tinto Building Low-Cost Lithium Business in Difficult Market -- Market Talk

8.12.2025 г., 22:01 ч. UTC

Пазарно говорене

Miners Poised to Do Well in 2026 -- Market Talk

8.12.2025 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Noble: Agreement With Borr Includes Sale of Noble Tom Prosser, Noble Mick O'Brien, Noble Regina Allen, Noble Resilient, Noble Resolute, Closing Expected in Early 2026 >NE

8.12.2025 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Noble: Agreement With Borr Comprises $210M in Cash and $150M in Seller Notes >NE

8.12.2025 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Noble: Agreement With Ocean Oilfield Drilling Anticipates the Sale of the Noble Resolve, Closing Is Expected in 2Q 2026, Upon Conclusion of Noble Resolve's Current Contract >NE

8.12.2025 г., 22:00 ч. UTC

Придобивния, сливания и поглъщания

Noble: To Sell Five Rigs to Borr Drilling Limited for $360M and One Rig to Ocean Oilfield Drilling for $64M in Cash >NE

8.12.2025 г., 21:51 ч. UTC

Пазарно говорене

US-Canada Rate Spreads Narrow Sharply After Record Gap -- Market Talk

8.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Tech, Media & Telecom Roundup: Market Talk

8.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Auto & Transport Roundup: Market Talk

8.12.2025 г., 21:50 ч. UTC

Пазарно говорене

Basic Materials Roundup: Market Talk

8.12.2025 г., 21:38 ч. UTC

Придобивния, сливания и поглъщания

Boeing Buys Company Responsible for Door Blowout. The Stock Rises. -- Barrons.com

8.12.2025 г., 21:38 ч. UTC

Придобивния, сливания и поглъщания

Paramount Makes $77.9 Billion Hostile Bid for Warner After Netflix Struck Deal -- 7th Update

8.12.2025 г., 21:36 ч. UTC

Пазарно говорене

Oil Oversupply to Show Up As Waterborne Stocks Land -- Market Talk

8.12.2025 г., 21:20 ч. UTC

Придобивния, сливания и поглъщания

Will the Netflix-Warner Bros. Merger Go Through? It Depends on How You Define Market Share. -- Barrons.com

8.12.2025 г., 21:12 ч. UTC

Придобивния, сливания и поглъщания

These Stocks Moved the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8.12.2025 г., 21:08 ч. UTC

Пазарно говорене

Rosenberg Turns 'Outright Bullish' on Canada Dollar -- Market Talk

8.12.2025 г., 20:38 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Netflix Co-CEOs Confident About Regulatory Approval for WBD Deal -- Market Talk

8.12.2025 г., 20:26 ч. UTC

Придобивния, сливания и поглъщания

These Stocks Are Moving the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

8.12.2025 г., 20:18 ч. UTC

Пазарно говорене

Придобивния, сливания и поглъщания

Netflix Isn't Looking to Make Cuts at Warner Bros. Discovery -- Market Talk

8.12.2025 г., 20:07 ч. UTC

Пазарно говорене

Oil Futures Snap Three-Session Winning Streak -- Market Talk

8.12.2025 г., 20:06 ч. UTC

Пазарно говорене

U.S. Natural Gas Pulls Back From Weather-Driven Highs -- Market Talk

8.12.2025 г., 20:05 ч. UTC

Пазарно говорене

Global Equities Roundup: Market Talk

8.12.2025 г., 20:05 ч. UTC

Пазарно говорене

Deere Offers Sales Growth Forecast Through 2030 -- Market Talk

8.12.2025 г., 20:01 ч. UTC

Пазарно говорене

Precious Metals Slip Ahead of Fed Decision -- Market Talk

Сравнение с други в отрасъла

Ценова промяна

Fulgent Genetics Inc Прогноза

Ценова цел

By TipRanks

16.65% нагоре

12-месечна прогноза

Среден 32.5 USD 16.65%

Висок 35 USD

Нисък 30 USD

Според 2 анализатори от Wall Street, предложили 12-месечна ценова цел за Fulgent Genetics Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

2 ratings

Купи

Задържане

Продай

Според 2 анализатори, дали борсови рейтинги на Fulgent Genetics Inc през последните 3 месеца.

Техническа оценка

By Trading Central

17.32 / 19.04Подкрепа & съпротива

Recent bearish events outweigh bullish events.

All events are bullish.

The bullish and bearish events are balanced.

Настроение

By Acuity

166 / 374 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Fulgent Genetics Inc

Fulgent Genetics, Inc., together with its subsidiaries, provides clinical diagnostic and therapeutic development solutions to physicians and patients in the United States and internationally. The company's clinical diagnostic solutions include molecular diagnostic testing; genetic testing; anatomic pathology laboratory tests and testing services, such as gastrointestinal pathology, dermatopathology, urologic pathology, breast pathology, neuropathology, and hematopathology; oncology tests and testing services; and sequencer services related to hereditary cancer, reproductive health, and other diseases. Its therapeutic development solutions focus on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform to enhance the therapeutic window and pharmacokinetic profile of new and existing cancer drugs. The company operates picture genetics platform, which includes gene probes, data suppression and comparison algorithms, adaptive learning software, and proprietary laboratory information management systems that helps customers to identify health markers in their personal DNA. It serves insurance, hospitals, medical institutions, other laboratories, governmental bodies, payors, municipalities and large corporations, and patients. The company was formerly known as Fulgent Diagnostics, Inc. and changed its name to Fulgent Genetics, Inc. in August 2016. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in El Monte, California.